Search results for: Jonathan W. Mink

Items from 1 to 20 out of 65 results

article

Pharmacological and neurosurgical management of cerebral palsy and dystonia: Clinical practice guideline update

Darcy Fehlings, Brenda Agnew, Hortensia Gimeno, Adrienne Harvey, more

Developmental Medicine & Child Neurology > 66 > 9 > 1133 - 1147

Dystonia, typically characterized by slow repetitive involuntary movements, stiff abnormal postures, and hypertonia, is common among individuals with cerebral palsy (CP). Dystonia can interfere with activities and have considerable impact on motor function, pain/comfort, and ease of caregiving. Although pharmacological and neurosurgical approaches are used clinically in individuals with CP and dystonia...

article

John Steele and Alternating Hemiplegia of Childhood Reply to: Obituary for Dr. John C. Steele (1934–2022)

Laura Silveira‐Moriyama, Jonathan W. Mink

Movement Disorders > 38 > 5 > 914 - 915

article

The President, Past President, Executive Director, and the Board of the Child Neurology Society Denounce Racism and Inequality

Phillip L. Pearl, Jonathan W. Mink, Bruce H. Cohen, Nigel Bamford, more

Annals of Neurology > 88 > 2 > 209 - 210

article

A Pediatric Neurology Perspective on Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute-Onset Neuropsychiatric Syndrome

Donald L. Gilbert, Jonathan W. Mink, Harvey S. Singer

The Journal of Pediatrics > 2018 > 199 > C > 243-251

article

Alterations in vestibular function in individuals with cervical dystonia and the effects of botulinum toxin treatment

Kelly L. Andrzejewski, Shiyang Ma, Ashley Owens, Michael T. Bull, more

Basal Ganglia > 2018 > 13 > C > 1-6

Individuals with cervical dystonia (CD) often report difficulty with balance and an altered perception of vertical. Previous studies have suggested a decreased proprioceptive response to stretch of neck muscle spindles in these patients, and impaired dynamic balance changes in individuals with tremor.Participants with CD were divided into three groups based on severity of tremor and dystonic position...

article

Phenotypes, genotypes, and the management of paroxysmal movement disorders

Laura Silveira‐Moriyama, Stjepana Kovac, Manju A Kurian, Henry Houlden, more

Developmental Medicine & Child Neurology > 60 > 6 > 559 - 565

As a consequence of the genomic revolution, a large number of publications describing paroxysmal movement disorders have been published in the last few years, shedding light on their molecular pathology. Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (PKD), paroxysmal nonkinesigenic dyskinesia (PNKD), and episodic ataxia type 1 or 2...

article

Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review

Darcy Fehlings, Leah Brown, Adrienne Harvey, Kate Himmelmann, more

Developmental Medicine & Child Neurology > 60 > 4 > 356 - 366

Aim To systematically review evidence for pharmacological/neurosurgical interventions for managing dystonia in individuals with cerebral palsy (CP) to inform a care pathway. Method Searches included studies with a minimum of five participants with dystonia in CP receiving oral baclofen, benzodiazepines (clonazepam, diazepam, lorazepam), clonidine, gabapentin, levodopa, trihexyphenidyl, botulinum...

article

Quantitative, clinically relevant acoustic measurements of focal embouchure dystonia

Aimee E. Morris, Scott A. Norris, Joel S. Perlmutter, Jonathan W. Mink

Movement Disorders > 33 > 3 > 449 - 458

Background: Focal embouchure dystonia impairs orofacial motor control in wind musicians and causes professional disability. A paucity of quantitative measures or rating scales impedes the objective assessment of treatment efficacy. Objectives: We quantified specific features of focal embouchure dystonia using acoustic measures and developed a metric to assess severity across multiple domains of symptomatic...

article

Basal ganglia mechanisms in action selection, plasticity, and dystonia

Jonathan W. Mink

European Journal of Paediatric Neurology > 2018 > 22 > 2 > 225-229

Basal ganglia circuits are organized to selected desired actions and to inhibit potentially competing unwanted actions. This is accomplished through a complex circuitry that is modified through development and learning. Mechanisms of neural plasticity underlying these modifications are increasingly understood, but new mechanisms continue to be discovered. Dystonia, a movement disorder characterized...

article

A proposed staging system for CLN3 disease (juvenile Batten disease)

Jonathan W. Mink, Justin D. Williams, Erika F. Augustine

Molecular Genetics and Metabolism > 2018 > 123 > 2 > S96

article

The unified Batten disease rating scale (UBDRS): Validation and reliability in an independent sample

Jonathan W. Mink, Miriam Nickel, Eva Wibbeler, Christoff Schwering, more

Molecular Genetics and Metabolism > 2018 > 123 > 2 > S95

article

Motor sequence awareness is impaired in dystonia despite normal performance

Molly J. Jaynes, Jonathan W. Mink

Annals of Neurology > 83 > 1 > 52 - 60

Objective Dystonia is a movement disorder that has been associated with impaired motor learning and sequence recognition. However, despite evidence that patients with dystonia have a reduced sense of agency, it is unclear whether dystonia is specifically associated with impaired recognition of a movement sequence. We have shown previously that performance consistency in the temporal and kinematic...

article

Screening tools for tic disorders—Focus on development or implementation?

Erika F. Augustine, Heather R. Adams, Jonathan W. Mink

Movement Disorders > 32 > 6 > 946 - 946

article

Management Strategies for CLN2 Disease

Ruth E. Williams, Heather R. Adams, Martin Blohm, Jessica L. Cohen-Pfeffer, more

Pediatric Neurology > 2017 > 69 > C > 102-112

CLN2 disease (neuronal ceroid lipofuscinosis type 2) is a rare, autosomal recessive, pediatric-onset, rapidly progressive neurodegenerative lysosomal storage disorder caused by tripeptidyl peptidase 1 (TPP1) enzyme deficiency, and is characterized by language delay, seizures, rapid cognitive and motor decline, blindness, and early death. No management guidelines exist and there is a paucity of published...

article

Management of movement disorders in children – Authors’ reply

Anne Koy, Jean-Pierre Lin, Terence D Sanger, Warren A Marks, more

The Lancet Neurology > 2016 > 15 > 13 > 1302-1303

article

“Complex” dystonia is not a category in the new 2013 consensus classification

Alberto Albanese, Kailash Bhatia, Mahlon R. DeLong, Stanley Fahn, more

Movement Disorders > 31 > 11 > 1758 - 1759

article

1.1 Suicidal Thoughts and Behaviors in Children and Adolescents With Chronic Tic Disorders

Joseph McGuire, Camille E. Hanks, Jonathan W. Mink, Joseph McGuire, more

Journal of the American Academy of Child & Adolescent Psychiatry > 2016 > 55 > 10(S) > S258

article

Intravenous Immunoglobulin Is Not an Effective Treatment for Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infection Obsessive-Compulsive Disorder

Jonathan W. Mink

Journal of the American Academy of Child & Adolescent Psychiatry > 2016 > 55 > 10 > 837-838

article

Temporal and kinematic consistency predict sequence awareness

Molly J. Jaynes, Marc H. Schieber, Jonathan W. Mink

Experimental Brain Research > 2016 > 234 > 10 > 3025-3036

Many human motor skills can be represented as a hierarchical series of movement patterns. Awareness of underlying patterns can improve performance and decrease cognitive load. Subjects (n = 30) tapped a finger sequence with changing stimulus-to-response mapping and a common movement sequence. Thirteen subjects (43 %) became aware that they were tapping a familiar movement sequence during the experiment...

article

Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions

Elsa Shapiro, Jessica Bernstein, Heather R. Adams, Ann J. Barbier, more

Molecular Genetics and Metabolism > 2016 > 118 > 2 > 65-69

Well-defined and reliable clinical outcome assessments are essential for determining whether a drug provides clinically meaningful treatment benefit for patients. In 2015, FDA convened a workshop, “Assessing Neurocognitive Outcomes in Inborn Errors of Metabolism.” Topics covered included special challenges of clinical studies of inborn errors of metabolism (IEMs) and other rare diseases; complexities...

Publication date

Last year (1)
Last 3 years (2)

Close

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

From:

To:
Set your own date range

INFONA - science communication portal

Search results for: Jonathan W. Mink

Pharmacological and neurosurgical management of cerebral palsy and dystonia: Clinical practice guideline update

John Steele and Alternating Hemiplegia of Childhood Reply to: Obituary for Dr. John C. Steele (1934–2022)

The President, Past President, Executive Director, and the Board of the Child Neurology Society Denounce Racism and Inequality

A Pediatric Neurology Perspective on Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute-Onset Neuropsychiatric Syndrome

Alterations in vestibular function in individuals with cervical dystonia and the effects of botulinum toxin treatment

Phenotypes, genotypes, and the management of paroxysmal movement disorders

Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review

Quantitative, clinically relevant acoustic measurements of focal embouchure dystonia

Basal ganglia mechanisms in action selection, plasticity, and dystonia

A proposed staging system for CLN3 disease (juvenile Batten disease)

The unified Batten disease rating scale (UBDRS): Validation and reliability in an independent sample

Motor sequence awareness is impaired in dystonia despite normal performance

Screening tools for tic disorders—Focus on development or implementation?

Management Strategies for CLN2 Disease

Management of movement disorders in children – Authors’ reply

“Complex” dystonia is not a category in the new 2013 consensus classification

1.1 Suicidal Thoughts and Behaviors in Children and Adolescents With Chronic Tic Disorders

Intravenous Immunoglobulin Is Not an Effective Treatment for Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infection Obsessive-Compulsive Disorder

Temporal and kinematic consistency predict sequence awareness

Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions

Filter options

Publication date

Keywords

Data set

Journal

INFONA - science communication portal

Search results for: Jonathan W. Mink

Add recipient

Sending message cancelled

Are you sure you want to cancel sending this message?

Send message

Filter options

Publication date

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

Keywords

Data set

Journal

Reporting an error / abuse

Sending the report failed

Accessibility options